Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Hematology
Volume 2017 (2017), Article ID 4109605, 8 pages
https://doi.org/10.1155/2017/4109605
Case Report

Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain

1Hematology Department, Hospital Regional Universitario de Málaga, Av. de Carlos Haya, s/n, 29010 Málaga, Spain
2Hematology Department, Hospital Universitario 12 de Octubre, Avda. Córdoba, s/n, 28041 Madrid, Spain
3Hematology Department, Hospital Universitari Vall d’Hebron, Passeig de la Vall d’Hebron 119-129, 08035 Barcelona, Spain
4Amgen S.A., Moll de Barcelona, Edifici Sud, Planta 7, 08039 Barcelona, Spain

Correspondence should be addressed to María-Eva Mingot-Castellano; moc.liamg@tognimem

Received 25 April 2017; Accepted 16 May 2017; Published 11 June 2017

Academic Editor: Masayuki Nagasawa

Copyright © 2017 María-Eva Mingot-Castellano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

María-Eva Mingot-Castellano, Carlos Grande-García, David Valcárcel-Ferreiras, Clara Conill-Cortés, and Loreto de Olivar-Oliver, “Sustained Remission in Patients with Primary Immune Thrombocytopenia after Romiplostim Tapering and Discontinuation: A Case Series in Real Life Management in Spain,” Case Reports in Hematology, vol. 2017, Article ID 4109605, 8 pages, 2017. doi:10.1155/2017/4109605